Eli Lilly | The Epoch Times

FDA Gives Eli Lilly’s Experimental COVID-19 Antibody Drug Emergency Clearance

U.S. drug regulators granted Eli Lilly’s COVID-19 antibody drug an emergency-use authorization on Monday, widening access to a therapy that has shown improvement in treating patients with mild to moderate ...

November 10, 2020BY Isabel van Brugen

Antibody Treatment Shows Improvement in Patients With Mild to Moderate Infection

Eli Lilly’s neutralizing antibody LY-CoV555 has shown improvement in treating patients with mild to moderate cases of the CCP ...

October 30, 2020BY Paula Liu

NIH Announces Halt to Eli Lilly Antibody Treatment on Hospitalized COVID-19 Patients

The National Institute of Allergy and Infectious Diseases (NIAID) announced in a statement that they have stopped clinical trials of ...

October 27, 2020BY Paula Liu

Eli Lilly Pauses COVID-19 Drug Trial Due to Safety Concerns

Eli Lilly announced on Tuesday that the government-sponsored clinical trial of its COVID-19 monoclonal antibody treatment has been ...

October 14, 2020BY Tom Ozimek

Drugmaker Eli Lilly Caps Insulin Costs at $35 as CCP Virus Crisis Deepens

Drugmaker Eli Lilly & Co. announced on April 7 that it has rolled out a scheme to cap ...

April 8, 2020BY Isabel van Brugen

How Much of Our Tax Money Goes to Big Pharma? A Lot.

After an 18 month investigation into the high cost of Gilead's hepatitis C drug Sovaldi—initially listed at $84,000 ...

February 20, 2016BY Martha Rosenberg

Drugmaker Lilly’s 2016 Forecast Misses Street Expectations

Eli Lilly has dropped a lower-than-expected 2016 forecast on Wall Street after wrapping up a year in which ...

January 5, 2016BY The Associated Press